ExpreS2ion Biotech Holding AB (publ)
EXPRS2
Rank in Stocks
#33787
Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its... Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
Share Price
$0.09325189
Last synced: 2026-11-09
Market Cap
$237.89K
Change (1 day)
-0.60%
Change (1 year)
-94.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ExpreS2ion Biotech Holding AB (publ) (EXPRS2)
Category
Healthcare
EPS for ExpreS2ion Biotech Holding AB (publ) (EXPRS2)
EPS as of June 2026 TTM: $-0.69
According to ExpreS2ion Biotech Holding AB (publ)'s latest financial reports, its current EPS (TTM) is $-0.69. At the end of 2025 the company had an EPS of $-1.45, an increase over its 2024 EPS of $-1.93.
EPS history for ExpreS2ion Biotech Holding AB (publ) from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.69 | -52.46% |
| 2025 | $-1.45 | -24.89% |
| 2024 | $-1.93 | -75.39% |
| 2023 | $-7.85 | -34.82% |
| 2022 | $-12.05 | 100.39% |
| 2021 | $-6.01 | -25.19% |
| 2020 | $-8.03 | 82.05% |
| 2019 | $-4.41 | -13.53% |
| 2018 | $-5.10 | 28.81% |
| 2017 | $-3.96 | 20.00% |
| 2016 | $-3.30 | -39.98% |
| 2015 | $-5.50 | -2,888.29% |
| 2014 | $0.20 | -66.53% |
| 2013 | $0.59 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -2,371.87% |
US
|
|
| $-7.07 | 925.68% |
US
|
|
| $-5.29 | 667.45% |
AU
|
|
| $12.88 | -1,968.58% |
BE
|
|
| $21.56 | -3,227.81% |
NL
|
Questions about ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS)
What is ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS)?
ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS) over the last twelve months is $-0.69, as of Jun 2026.
What was ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS) in 2025?
In 2025, ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS) was $-1.45, compared with $-1.93 in 2024.
How has ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS) was highest in 2025 ($-1.45) and lowest in 2022 ($-12.05).
How does ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS) compare with similar companies?
ExpreS2ion Biotech Holding AB (publ)'s earnings per share (EPS) ($-0.69) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.